Vivos Therapeutics, Inc. (VVOS) Stock Analysis & Investment Frameworks

Vivos Therapeutics, Inc. (VVOS) stock analysis on Invetso. Review Vivos Therapeutics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Vivos Therapeutics, Inc. Company Overview

Vivos Therapeutics, Inc. Key Financial Metrics

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Vivos Therapeutics, Inc. Investment Frameworks

Invetso analyzes Vivos Therapeutics, Inc. (VVOS) across the following frameworks:

Explore More VVOS Research